• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药、清肺排毒汤和宣肺败毒汤抑制巨噬细胞中细胞因子产生及NF-κB信号通路:对2019冠状病毒病(COVID-19)治疗的启示

Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy.

作者信息

Li Yujia, Li Bin, Wang Pan, Wang Qinghua

机构信息

Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.

The Joint Laboratory on Transfusion-transmitted Diseases (TTD) Between Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Nanning Blood Center, Nanning, China.

出版信息

Front Pharmacol. 2021 Oct 26;12:722126. doi: 10.3389/fphar.2021.722126. eCollection 2021.

DOI:10.3389/fphar.2021.722126
PMID:34764867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8576273/
Abstract

Qingfei Paidu decoction (QPD) and Xuanfei Baidu decoction (XBD) are two typical traditional Chinese medicines with proven efficacy for the treatment of SARS-CoV-2, although the underlying mechanism is not well defined. Blunted immune response and enhanced production of pro-inflammatory cytokines (cytokine storm) are two main features observed in patients infected with SARS-CoV-2. Analysis based on network pharmacology has revealed that both QPD and XBD played an important role in the regulation of host immunity. We therefore investigated the role of QPD and XBD in the modulation of innate immunity , focusing on the type 1 interferon (IFN) signaling pathway in A549 cells and pro-inflammatory cytokine production in macrophages. A549 cells were treated with QPD or XBD and the production of endogenous IFNα and IFNβ as well as the expression levels of some interferon-stimulated genes (ISGs) were detected by reverse transcriptase-quantitative PCR (RT-qPCR). Macrophages derived from THP-1 cells were treated with QPD or XBD and their pro-inflammatory cytokine expression levels were measured by RT-qPCR, 6 h post LPS stimulation. In addition, the expression levels of some pro-inflammatory cytokines were further analyzed by ELISA. The effect of QPD and XBD on the NF-κB signaling pathway and the pinocytosis activity of THP-1-derived macrophages were evaluated by Western blot and neutral red uptake assay, respectively. Although QPD and XBD showed very little effect on the type 1 IFN signaling pathway in A549 cells, either QPD or XBD markedly inhibited the production of pro-inflammatory markers including interleukin-6, tumor necrosis factor-α, monocyte chemotactic protein-1, and chemokine ligand 10 in THP-1-derived M1 macrophages. In addition, the phosphorylation of IκBα and NF-κB p65 during the process of macrophage polarization was significantly suppressed following QPD or XBD treatment. QPD and XBD also suppressed the pinocytosis activity of macrophages. QPD and XBD have been shown to have robust anti-inflammatory activities . Our study demonstrated that both QPD and XBD decreased pro-inflammatory cytokine expression, inhibited the activation of the NF-κB signaling pathway, and blunted pinocytosis activity in THP-1-derived macrophages.

摘要

清肺排毒汤(QPD)和宣肺败毒汤(XBD)是两种经证实对治疗新型冠状病毒肺炎有效的典型中药,尽管其潜在机制尚不完全清楚。免疫反应减弱和促炎细胞因子(细胞因子风暴)产生增加是新型冠状病毒肺炎患者的两个主要特征。基于网络药理学的分析表明,QPD和XBD在调节宿主免疫方面均发挥重要作用。因此,我们研究了QPD和XBD在调节固有免疫中的作用,重点关注A549细胞中的1型干扰素(IFN)信号通路以及巨噬细胞中促炎细胞因子的产生。用QPD或XBD处理A549细胞,通过逆转录定量PCR(RT-qPCR)检测内源性IFNα和IFNβ的产生以及一些干扰素刺激基因(ISG)的表达水平。用QPD或XBD处理源自THP-1细胞的巨噬细胞,在LPS刺激6小时后,通过RT-qPCR测量其促炎细胞因子表达水平。此外,通过酶联免疫吸附测定(ELISA)进一步分析一些促炎细胞因子的表达水平。分别通过蛋白质免疫印迹法和中性红摄取试验评估QPD和XBD对NF-κB信号通路的影响以及THP-1衍生巨噬细胞的胞饮活性。尽管QPD和XBD对A549细胞中的1型IFN信号通路影响很小,但QPD或XBD均显著抑制源自THP-1的M1巨噬细胞中促炎标志物的产生,包括白细胞介素-6、肿瘤坏死因子-α、单核细胞趋化蛋白-1和趋化因子配体10。此外,在QPD或XBD处理后,巨噬细胞极化过程中IκBα和NF-κB p65的磷酸化被显著抑制。QPD和XBD还抑制了巨噬细胞的胞饮活性。QPD和XBD已被证明具有强大的抗炎活性。我们的研究表明,QPD和XBD均降低了促炎细胞因子的表达,抑制了NF-κB信号通路的激活,并减弱了THP-1衍生巨噬细胞的胞饮活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/ee90ef566a1f/fphar-12-722126-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/7925b9bfa1b3/fphar-12-722126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/a5b04deca685/fphar-12-722126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/d51b5808a19a/fphar-12-722126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/baf978231522/fphar-12-722126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/ee90ef566a1f/fphar-12-722126-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/7925b9bfa1b3/fphar-12-722126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/a5b04deca685/fphar-12-722126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/d51b5808a19a/fphar-12-722126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/baf978231522/fphar-12-722126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e6e/8576273/ee90ef566a1f/fphar-12-722126-g005.jpg

相似文献

1
Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy.中药、清肺排毒汤和宣肺败毒汤抑制巨噬细胞中细胞因子产生及NF-κB信号通路:对2019冠状病毒病(COVID-19)治疗的启示
Front Pharmacol. 2021 Oct 26;12:722126. doi: 10.3389/fphar.2021.722126. eCollection 2021.
2
Gentiopicroside (GENT) protects against sepsis induced by lipopolysaccharide (LPS) through the NF-κB signaling pathway.龙胆苦苷(GENT)通过核因子κB(NF-κB)信号通路对脂多糖(LPS)诱导的脓毒症具有保护作用。
Ann Transl Med. 2019 Dec;7(23):731. doi: 10.21037/atm.2019.11.126.
3
Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment.清肺排毒汤联合西药治疗 COVID-19 的临床回顾性研究。
Biomed Pharmacother. 2020 Sep;129:110500. doi: 10.1016/j.biopha.2020.110500. Epub 2020 Jul 4.
4
Geraniin Inhibits LPS-Induced THP-1 Macrophages Switching to M1 Phenotype via SOCS1/NF-κB Pathway.老鹳草素通过SOCS1/NF-κB途径抑制脂多糖诱导的THP-1巨噬细胞向M1表型转变。
Inflammation. 2016 Aug;39(4):1421-33. doi: 10.1007/s10753-016-0374-7.
5
Er-Miao-San, a traditional herbal formula containing Rhizoma Atractylodis and Cortex Phellodendri inhibits inflammatory mediators in LPS-stimulated RAW264.7 macrophages through inhibition of NF-κB pathway and MAPKs activation.二妙散,一种含有苍术和黄柏的传统草药配方,通过抑制核因子κB通路和丝裂原活化蛋白激酶的激活,抑制脂多糖刺激的RAW264.7巨噬细胞中的炎症介质。
J Ethnopharmacol. 2014 Jul 3;154(3):711-8. doi: 10.1016/j.jep.2014.04.042. Epub 2014 May 6.
6
Xuanfei Baidu Decoction suppresses complement overactivation and ameliorates IgG immune complex-induced acute lung injury by inhibiting JAK2/STAT3/SOCS3 and NF-κB signaling pathway.宣肺百度汤通过抑制 JAK2/STAT3/SOCS3 和 NF-κB 信号通路抑制补体过度激活,改善 IgG 免疫复合物诱导的急性肺损伤。
Phytomedicine. 2023 Jan;109:154551. doi: 10.1016/j.phymed.2022.154551. Epub 2022 Nov 21.
7
Enoxaparin sodium bone cement plays an anti-inflammatory immunomodulatory role by inducing the polarization of M2 macrophages.依诺肝素钠骨水泥通过诱导 M2 巨噬细胞极化发挥抗炎免疫调节作用。
J Orthop Surg Res. 2023 May 23;18(1):380. doi: 10.1186/s13018-023-03865-8.
8
Protection effects of mice liver and lung injury induced by coronavirus infection of Qingfei Paidu decoction involve inhibition of the NLRP3 signaling pathway.清肺排毒汤对冠状病毒感染引起的小鼠肺、肝损伤的保护作用涉及抑制 NLRP3 信号通路。
J Ethnopharmacol. 2024 Mar 1;321:117512. doi: 10.1016/j.jep.2023.117512. Epub 2023 Nov 30.
9
Wutou decoction attenuates the synovial inflammation of collagen-induced arthritis rats via regulating macrophage M1/M2 type polarization.乌头汤通过调控巨噬细胞 M1/M2 型极化抑制胶原诱导性关节炎大鼠滑膜炎症。
J Ethnopharmacol. 2023 Jan 30;301:115802. doi: 10.1016/j.jep.2022.115802. Epub 2022 Oct 6.
10
Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy.清肺排毒汤对药物代谢酶的抑制作用:COVID-19 药物治疗中药物-药物相互作用的意义。
Food Chem Toxicol. 2021 Mar;149:111998. doi: 10.1016/j.fct.2021.111998. Epub 2021 Jan 19.

引用本文的文献

1
Traditional Chinese Medicine for Viral Pneumonia Therapy: Pharmacological Basis and Mechanistic Insights.用于治疗病毒性肺炎的中医药:药理基础与作用机制洞察
Int J Biol Sci. 2025 Jan 6;21(3):989-1013. doi: 10.7150/ijbs.105086. eCollection 2025.
2
Cytokine Storm in COVID-19: Insight into Pathological Mechanisms and Therapeutic Benefits of Chinese Herbal Medicines.新型冠状病毒肺炎中的细胞因子风暴:中草药的病理机制及治疗作用洞察
Medicines (Basel). 2024 Jul 18;11(7):14. doi: 10.3390/medicines11070014.
3
Xuanfei Baidu decoction in the treatment of coronavirus disease 2019 (COVID-19): Efficacy and potential mechanisms.

本文引用的文献

1
Proinflammatory Responses in SARS-CoV-2 and Soluble Spike Glycoprotein S1 Subunit Activated Human Macrophages.SARS-CoV-2 和可溶性 Spike 糖蛋白 S1 亚单位激活的人巨噬细胞中的促炎反应。
Viruses. 2023 Mar 15;15(3):754. doi: 10.3390/v15030754.
2
SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway.SARS-CoV-2 刺突蛋白通过 TLR2 依赖性激活 NF-κB 途径诱导炎症反应。
Elife. 2021 Dec 6;10:e68563. doi: 10.7554/eLife.68563.
3
SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
宣肺败毒汤治疗新型冠状病毒肺炎(COVID-19):疗效与潜在机制
Heliyon. 2023 Aug 19;9(9):e19163. doi: 10.1016/j.heliyon.2023.e19163. eCollection 2023 Sep.
4
A retrospective study of Reyanning mixture in elderly patients infected with SARS-CoV-2 Omicron variant.连花清瘟合剂治疗感染新型冠状病毒奥密克戎变异株老年患者的回顾性研究
Front Pharmacol. 2023 Jul 20;14:1185122. doi: 10.3389/fphar.2023.1185122. eCollection 2023.
5
The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine.新型冠状病毒肺炎恢复期的病理机制及其中医药治疗
Front Pharmacol. 2023 Jan 10;13:1054312. doi: 10.3389/fphar.2022.1054312. eCollection 2022.
6
Comparing the effects of three decoctions for coronavirus disease 2019 on severe acute respiratory syndrome coronavirus 2-related toll-like receptors-mediated inflammations.比较三种新冠肺炎方剂对严重急性呼吸综合征冠状病毒 2 相关 Toll 样受体介导的炎症的影响。
J Tradit Chin Med. 2023 Feb;43(1):51-59. doi: 10.19852/j.cnki.jtcm.2023.01.006.
7
Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models.宣肺百度方通过抑制 NF-κB 和 MAPK 通路缓解 LPS 诱导的 ALI 和炎症模型中受损的线粒体动力学和激活的 NLRP3 炎性体。
Phytomedicine. 2023 Jan;108:154545. doi: 10.1016/j.phymed.2022.154545. Epub 2022 Nov 9.
8
Therapeutic effects of herbal-medicine combined therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials.中药联合疗法治疗新型冠状病毒肺炎的疗效:一项随机对照试验的系统评价与Meta分析
Front Pharmacol. 2022 Sep 1;13:950012. doi: 10.3389/fphar.2022.950012. eCollection 2022.
9
Bioactive natural products in COVID-19 therapy.用于新冠治疗的生物活性天然产物。
Front Pharmacol. 2022 Aug 19;13:926507. doi: 10.3389/fphar.2022.926507. eCollection 2022.
10
The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.缺血再灌注损伤在类风湿性关节炎、长新冠和 ME/CFS 等慢性、复发性疾病中的潜在作用:证据、机制和治疗意义。
Biochem J. 2022 Aug 31;479(16):1653-1708. doi: 10.1042/BCJ20220154.
SARS-CoV-2/ACE2 相互作用抑制 IRAK-M 的表达并促进巨噬细胞中促炎细胞因子的产生。
Front Immunol. 2021 Jun 23;12:683800. doi: 10.3389/fimmu.2021.683800. eCollection 2021.
4
Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.热毒宁注射液治疗 COVID-19 的疗效和安全性及其对 SARS-CoV-2 的抑制作用。
J Ethnopharmacol. 2021 Oct 28;279:114367. doi: 10.1016/j.jep.2021.114367. Epub 2021 Jun 24.
5
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.Toll样受体2(TLR2)可识别严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的包膜蛋白以产生炎性细胞因子。
Nat Immunol. 2021 Jul;22(7):829-838. doi: 10.1038/s41590-021-00937-x. Epub 2021 May 7.
6
Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China.中国住院 COVID-19 合并高血压患者的死亡结局预测因素。
Clin Respir J. 2021 Aug;15(8):915-924. doi: 10.1111/crj.13382. Epub 2021 May 20.
7
Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.中医药治疗 COVID-19 和其他病毒感染:疗效和机制。
Pharmacol Ther. 2021 Sep;225:107843. doi: 10.1016/j.pharmthera.2021.107843. Epub 2021 Mar 31.
8
The important herbal pair for the treatment of COVID-19 and its possible mechanisms.用于治疗新型冠状病毒肺炎的重要药对及其可能机制。
Chin Med. 2021 Mar 3;16(1):25. doi: 10.1186/s13020-021-00427-0.
9
SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages.严重急性呼吸综合征冠状病毒2型刺突蛋白S1亚基通过Toll样受体4信号通路在小鼠和人类巨噬细胞中诱导促炎反应。
Heliyon. 2021 Feb 2;7(2):e06187. doi: 10.1016/j.heliyon.2021.e06187. eCollection 2021 Feb.
10
Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.网络药理学与实验验证揭示麻杏石甘汤防治 2019 年冠状病毒病(COVID-19)的潜在作用。
J Ethnopharmacol. 2021 May 10;271:113854. doi: 10.1016/j.jep.2021.113854. Epub 2021 Jan 26.